The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...

However, certain groups, particularly older adults and infants under six months old, may develop more severe symptoms and could require hospitalization. The CDC said that symptoms of RSV infection ...

RSV is a common, but highly infectious, respiratory virus that affects the breathing system, particularly in young children ...

Human Metapneumovirus (HMPV) is a respiratory virus that may not be on most folk’s radars, but it’s more common than you ...

Alone and in combination with other lower respiratory tract disease signs and symptoms, dyspnea is the best predictor of severe RSV outcomes.

The U.S. is seeing a "quad-demic" as cases of COVID-19, flu, RSV and norovirus spread at the same time. Experts said this is ...

The following is a summary of “Respiratory syncytial virus vaccine effectiveness among US veterans, September, 2023 to March, 2024: a target trial emulation study,” published in the January 2025 issue ...

The study, published Jan. 20 in The Lancet Infectious Diseases, found the vaccine to be 78% effective against RSV infection, 79% effective against emergency department and urgent care visits and 80% ...

A virus rapidly spreading in China is also circulating in the United States, causing concern among health experts.

As of Jan. 20, the CDC reports that RSV activity has peaked in most of the U.S., particularly among young children—a group ...

RSV is a common respiratory virus that causes mild, cold-like symptoms in healthy adults. Like similar viruses, it infects the nose, throat and lungs, making it difficult to tell apart from other ...